Hsbc Holdings PLC Purchases 65,488 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Hsbc Holdings PLC lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 16.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 452,842 shares of the medical device company’s stock after purchasing an additional 65,488 shares during the period. Hsbc Holdings PLC owned 0.23% of Cooper Companies worth $39,547,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the business. Benjamin F. Edwards & Company Inc. grew its position in shares of Cooper Companies by 248.6% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock worth $25,000 after buying an additional 174 shares during the last quarter. Innealta Capital LLC purchased a new position in Cooper Companies during the 2nd quarter valued at $25,000. Covestor Ltd raised its holdings in Cooper Companies by 305.9% in the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock worth $28,000 after purchasing an additional 208 shares in the last quarter. Crewe Advisors LLC lifted its position in shares of Cooper Companies by 286.4% in the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after purchasing an additional 252 shares during the period. Finally, Tortoise Investment Management LLC boosted its stake in shares of Cooper Companies by 75.4% during the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock valued at $34,000 after purchasing an additional 169 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Insider Transactions at Cooper Companies

In related news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at $18,267,624.69. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of the business’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Albert G. White III sold 114,992 shares of the stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the transaction, the chief executive officer now directly owns 165,273 shares in the company, valued at $18,267,624.69. The disclosure for this sale can be found here. Insiders sold 256,373 shares of company stock worth $27,637,427 over the last quarter. 2.00% of the stock is currently owned by insiders.

Cooper Companies Stock Down 0.5 %

NASDAQ:COO opened at $110.49 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The firm has a market cap of $22.00 billion, a P/E ratio of 64.99, a P/E/G ratio of 2.60 and a beta of 0.98. The Cooper Companies, Inc. has a fifty-two week low of $75.93 and a fifty-two week high of $112.38. The firm has a 50-day simple moving average of $97.54 and a two-hundred day simple moving average of $95.48.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.05. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.84 earnings per share. Analysts predict that The Cooper Companies, Inc. will post 3.66 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on COO shares. Morgan Stanley increased their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 10th. Piper Sandler raised their target price on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Robert W. Baird upped their price target on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Finally, Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and upped their target price for the stock from $107.00 to $115.00 in a research report on Tuesday, July 16th. Four research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat, Cooper Companies has an average rating of “Moderate Buy” and an average price target of $115.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.